Groton, CT, United States of America

Longfei Xie

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Pfizer Corporation. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Longfei Xie. Retrieved from https://idiyas.com/inventor/longfei-xie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Biography of Longfei Xie

Introduction: Longfei Xie is an accomplished inventor based in Groton, Connecticut. He has made significant contributions to the field of medical research, particularly in the development of novel cytotoxic compounds.

Latest Patents: Longfei Xie holds a patent for "Tubulysin analogs and methods for their preparation." This invention focuses on innovative cytotoxic tubulysin analogs and derivatives, which can be utilized in antibody drug conjugates. These advancements are aimed at treating various medical conditions, including cancer.

Career Highlights: Longfei Xie is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to engage in cutting-edge research and development in the pharmaceutical industry.

Collaborations: Throughout his career, Longfei has collaborated with notable colleagues, including Chakrapani Subramanyam and Lawrence Nathan Tumey. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion: Longfei Xie's innovative work in the field of cytotoxic compounds exemplifies his dedication to improving medical treatments. His contributions continue to have a significant impact on cancer research and therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…